MIRM

Mirum Pharmaceuticals Stock Analysis

AI Rating

Great
  • Quality4/10
  • Growth↑ 7/10
  • Momentum↑ 9/10
Mirum Pharmaceuticals sales and earnings growth
MIRM Growth
Good
  • Revenue Y/Y↑ 53.66%
  • EPS Y/Y↑ 59.13%
  • FCF Y/Y↑ 2116.29%
Mirum Pharmaceuticals gross and profit margin trends
MIRM Profitability
Neutral
  • Gross margin ↑ 79.90%
  • EPS margin↓ -8.80%
  • ROIC↓ -6.30%
Mirum Pharmaceuticals net debt vs free cash flow
MIRM Risk
Good
  • Debt / Equity↓ 1.1
  • Debt / FCF↓ 0.8
  • Interest coverage↓ -1.8

Mirum Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.

More Biotechnology stocks ↗